Stay updated on Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T17:32:15.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T06:49:06.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 as the page version. This is a minor update that does not change study content or eligibility details.
    Difference
    0.0%
    Check dated 2026-02-13T16:28:56.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1, with no user-facing changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:31:32.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 removed, a minor UI/documentation update with no impact on the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:28:26.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    Show glossary was added and the page revision updated to v3.4.0; minor wording and capitalization adjustments were made to QC-related labels (Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria, and No FEAR Act Data vs No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:15:12.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Nemolizumab in Atopic Dermatitis Clinical Trial page.